Preclinical data plays a crucial role in the MFDS drug registration process by providing initial evidence of a drug’s safety and biological activity. This data, obtained from laboratory and animal studies, helps the MFDS evaluate potential risks, informs clinical trial design, and supports the overall assessment of the drug’s efficacy before human testing.